D-Dopa Tablet 250 mg+25 mg is a combination medication containing Levodopa and Carbidopa, widely used in the management of Parkinson’s disease and other movement disorders associated with dopamine deficiency. Parkinson’s disease is characterized by progressive degeneration of dopamine-producing neurons in the brain, leading to symptoms such as tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability.

Levodopa serves as a precursor to dopamine, replenishing the deficient neurotransmitter in the brain, while Carbidopa inhibits peripheral metabolism of Levodopa, allowing more of the drug to reach the central nervous system. This combination enhances the efficacy of therapy while reducing common side effects such as nausea and vomiting.

D-Dopa Tablet 250 mg+25 mg is formulated for oral administration, providing a convenient and reliable way to improve motor control and daily functioning in patients with Parkinson’s disease.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Levodopa crosses the blood-brain barrier and is converted to dopamine in the brain, replenishing depleted levels and improving communication between neurons in areas controlling movement.

Carbidopa inhibits the enzyme aromatic L-amino acid decarboxylase (DOPA decarboxylase) in peripheral tissues, preventing premature conversion of Levodopa to dopamine outside the brain. This increases the amount of Levodopa that reaches the brain and reduces peripheral side effects such as nausea, vomiting, and hypotension.

Together, Levodopa and Carbidopa restore dopaminergic activity in the central nervous system, improving motor symptoms and enhancing patient quality of life.

Indications

D-Dopa Tablet 250 mg+25 mg is primarily indicated for:

• Parkinson’s disease – to control motor symptoms such as tremors, stiffness, and slow movements

• Parkinsonism due to other causes, including post-encephalitic and drug-induced Parkinsonism

• Adjunct therapy in severe movement disorders where dopamine replacement is required

It is suitable for both newly diagnosed patients and those requiring dose adjustments in long-term Parkinson’s management.

Dosage and Administration

The dosage of D-Dopa Tablet 250 mg+25 mg varies depending on the severity of symptoms, patient age, and individual response. Tablets are usually taken orally, with or without food, as prescribed by a healthcare professional.

• Initial doses are typically one tablet 2–3 times daily, which may be gradually increased based on response and tolerability.

• It is important to follow the prescribed dosing schedule to maintain stable dopamine levels and minimize motor fluctuations.

• Regular follow-up with a physician is necessary to adjust doses over time, as Parkinson’s disease progresses and individual needs change.

Precautions and Warnings

• Use with caution in patients with cardiovascular disease, glaucoma, or psychiatric disorders.

• Abrupt discontinuation may worsen symptoms or cause a sudden worsening of movement control.

• May cause dizziness or drowsiness; avoid driving or operating machinery until response is known.

• Inform your physician of any concurrent medications, particularly MAO inhibitors, antipsychotics, or antihypertensives.

• Periodic monitoring of blood pressure, liver, and kidney function may be recommended.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include:

• Nausea, vomiting, or loss of appetite

• Dizziness or orthostatic hypotension

• Involuntary movements (dyskinesia) with long-term use

• Sleep disturbances or vivid dreams

• Rarely, psychiatric symptoms such as hallucinations or confusion

Side effects can often be minimized by dose adjustment, timing of administration, or dietary considerations.

Storage Instructions

Store D-Dopa Tablet 250 mg+25 mg in a cool, dry place, protected from light and moisture. Keep out of reach of children.

D-Dopa Tablet 250 mg+25 mg is a cornerstone therapy for Parkinson’s disease, offering effective symptom control, improved mobility, and enhanced quality of life through the synergistic action of Levodopa and Carbidopa.